Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo LtdfiledCriticalKanebo Ltd
Priority to JP10469983ApriorityCriticalpatent/JPS59231092A/ja
Publication of JPS59231092ApublicationCriticalpatent/JPS59231092A/ja
Publication of JPH0358352B2publicationCriticalpatent/JPH0358352B2/ja
Uso de derivados de rifamicina para la fabricacion de un medicamento para el tratamiento de enfermedades causadas por infecciones de helicobacter pylori.
Dérivés de la tryptamine et de la thiényloxypropanolamine, procédé pour leur préparation, compositions pharmaceutiques les contenant et préparation de celles-ci
(-)-Alpha-(2-(bis(1-méthyléthyl)amino)éthyl)-alpha-phényl-2-pyridineacétamide et ses sels pharmaceutiquement acceptables, procédé pour leur préparation et compositions qui les contiennent